NCT07210996View on ClinicalTrials.gov

A Study to Evaluate the Relative Bioavailability of Pimicotinib Capsules Containing Free Base in Different Proportions in Healthy Subjects

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 12, 2025

Primary Completion Date

October 6, 2025

Study Completion Date

October 30, 2025

Conditions
Pharmacokinetics in Healthy Volunteers
Interventions
DRUG

pimicotinib capsules

pimicotinib capsules

Trial Locations (1)

Unknown

The First Hospital of Jilin University, Changchun

Sponsors
All Listed Sponsors
lead

Abbisko Therapeutics Co, Ltd

INDUSTRY